EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly report of Northwest Biotherapeutics, Inc. ("the
Company") on Form 10-Q for the period ending September 30, 2003, as filed with
the Securities and Exchange Commission on the date hereof ("the Report"), I,
Larry L. Richards, Controller of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, to the best of my knowledge and belief, that:

        (1) The Report fully complies with the requirements of section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

        (2) The information contained in the Report fairly presents, in all
            material respects the financial condition and results of operations
            of the Company.

                                     /s/ Larry L. Richards
                                     _________________________________________
                                     Larry L. Richards
                                     Controller (Principal Financial and
                                     Accounting Officer)
                                     November 13, 2003

        A signed original of this written statement required by Section 906 has
        been provided to the Company and will be retained by the Company and
        forwarded to the Securities and Exchange Commission or its staff upon
        request.